← Back
$HRTX All transactions

HERON THERAPEUTICS, INC. /DE/

A

$ Value

Shares

37,879

Price

Filed

Nov 12

Insider

Name

Cusack Thomas

Title

CIK

0002094824

Roles

Director

Transaction Details

Transaction Date

2025-11-08

Code

A

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

37,879

Footnotes

The shares were granted as restricted stock units which vest in 16 equal quarterly installments beginning one quarter after the date of grant. | Each restricted stock unit represents a contingent right to receive one share of common stock. | The stock options vest and become exercisable in 48 equal monthly installments beginning one month after the date of grant.

Filing Info

Accession No.

0001193125-25-276244

Form Type

4

Issuer CIK

0000818033

Cusack Thomas's History

Date Ticker Type Value
2026-01-30 HRTX A $0
2025-11-08 HRTX A
2025-11-08 HRTX A $250K

Other Insiders at HRTX (90d)

Insider Bought Sold Last
Forbes William P
EVP, Chief Development Officer
2026-04-19
Collard Craig A
Chief Executive Officer
2026-04-19
Johnson Craig A 2026-01-30
Duarte Ira
EVP, Chief Financial Officer
2026-04-19
Christian Waage 2026-01-30
Kaseta Michael 2026-01-30
Dissanaike Sharmila 2026-01-30
Morgan Adam 2026-01-30
Hensley Mark Earl
Chief Operating Officer
2026-01-30
Cusack Thomas 2026-01-30